Statistics
Total Visits
| Views | |
|---|---|
| CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: Results of the HE22A99 trial of the hellenic cooperative oncology group | 168 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: Results of the HE22A99 trial of the hellenic cooperative oncology group | 3 | 0 | 4 | 10 | 6 | 4 | 2 |
Top country views
| Views | |
|---|---|
| United States | 73 |
| Poland | 52 |
| China | 17 |
| France | 4 |
| Sweden | 4 |
| Australia | 3 |
| Canada | 2 |
| Germany | 2 |
| Ireland | 2 |
| Argentina | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 52 |
| Louisville | 9 |
| Boardman | 8 |
| Des Moines | 7 |
| San Ramon | 7 |
| Falls Church | 6 |
| Ann Arbor | 5 |
| San Diego | 5 |
| Ashburn | 4 |
| Beijing | 4 |